In early 2024, Melodiol Global Health (ASX: ME1), formerly known as Creso Pharma, faced scrutiny from the ASX, regarding corporate governance and financial disclosure which led to a major restructure and rebrand, but now the time has come to offload a major asset in an attempt for survival under its mounting debt obligations. Melodiol is
Read More
Recreational cannabis use has been a global topic for debate in the past few years but cannabinoids, a naturally occurring compound in cannabis, are now gaining momentum as a treatment for managing pain, inflammation and various mental health conditions like depression and PTSD. For the past several months, Melodiol Global Health’s (ASX: ME1) subsidiary, Health
Read More
With just four months of operating cash in the bank according to last month’s quarterly report, cannabis company Creso Pharma (ASX: CPH) are back in the headlines inking deals with the latest collaborative agreement to potentially enter the Australian body care market via Dr Pickles. Key to the non-binding Heads of Agreement (HoA) signed is
Read More
There is an increasingly growing body of research globally into the use of psychedelic medicines to treat various health conditions. To date, this research has produced highly encouraging results and has promoted the development of an extensive psychedelic industry, which has kicked off in North America and the United Kingdom. The industry has now made
Read More
Putting behind them the drama of 2021 which resulted in their former Chairman’s offices being raided by Australian Federal Police, medicinal cannabis company Creso Pharma (ASX: CPH) has kicked off the new year with a bang, confirming their entry into the lucrative US market through the acquisition of Sierra Sage Herbs. Founded in 2008 by
Read More
According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime. Treatment is somewhat limited to prescription medications and psychotherapy. However, the current mental health crisis has seen researchers and practitioners alike wondering- is there a better way to approach these frighteningly common conditions? Enter psychedelics,
Read More